Glenn Herring

Glenn Herring, Technical Operations Consultant, Halo

Articles by Glenn Herring

Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands

August 17th 2026

Glenn Herring, Halo Pharma, discusses its new sterile fill-finish platform: Groninger/SKAN tech, GMP design, and 2026 qualification timeline.

Inside Halo’s New Fill-Finish Platform

ByGlenn Herring,Zachary Zubulake

August 12th 2026

Glenn Herring, Halo Pharma, details the CDMO's new sterile fill-finish platform, Groninger/SKAN tech, GMP/Annex 1 design, and 2026 qualification timeline.

Latest Updated Articles

Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands
August 17th 2026

Glenn Herring

Articles by Glenn Herring

Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands

Inside Halo’s New Fill-Finish Platform

Latest Updated Articles

Trending on Pharmaceutical Technology

Regulatory Roundup—August 2026

Lilly's $2.875B Merida Deal Has Implications for Autoantibody Diseases

What to Know from the FDA’s End of August Activity

From Detection to Prediction: Analytical Approaches for Nitrosamine Risk

PharmTech Weekly Roundup—August 28, 2026